Graphene and its derivatives: understanding the main chemical and medicinal chemistry roles for biomedical applications

TM Magne, T de Oliveira Vieira, LMR Alencar… - Journal of nanostructure …, 2022 - Springer
Over the past few years, there has been a growing potential use of graphene and its
derivatives in several biomedical areas, such as drug delivery systems, biosensors, and …

Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis

A Taheriazam, GGY Abad, S Hajimazdarany… - Journal of Controlled …, 2023 - Elsevier
Nanotechnology is a growing field, with many potential biomedical applications of
nanomedicine for the treatment of different diseases, particularly cancer, on the horizon …

Doxorubicin-loaded graphene oxide nanocomposites in cancer medicine: stimuli-responsive carriers, co-delivery and suppressing resistance

M Ashrafizadeh, H Saebfar, MH Gholami… - Expert opinion on …, 2022 - Taylor & Francis
Introduction The application of doxorubicin (DOX) in cancer therapy has been limited due to
its drug resistance and poor internalization. Graphene oxide (GO) nanostructures have the …

Safety assessment of graphene acid and cyanographene: Towards new carbon-based nanomedicine

T Malina, C Hirsch, A Rippl, D Panacek, K Polakova… - Carbon, 2023 - Elsevier
Graphene oxide (GO) has been intensively studied in last decades as a promising delivery
nanoplatform. Although it surpasses the pristine graphene in its hydrophilic properties …

Graphene quantum dots decorated with imatinib for leukemia treatment

DM Felix, LMR Alencar, FD de Menezes… - Journal of drug delivery …, 2021 - Elsevier
The use of graphene quantum dots as biomedical device and drug delivery system has
been increasing. This nano-platform of pure carbon has showed unique properties and …

Influence of TiO2 and ZnO Nanoparticles on α-Synuclein and β-Amyloid Aggregation and Formation of Protein Fibrils

N Slekiene, V Snitka, I Bruzaite, A Ramanavicius - Materials, 2022 - mdpi.com
The most common neurological disorders, ie, Parkinson's disease (PD) and Alzheimer's
disease (AD), are characterized by degeneration of cognitive functions due to the loss of …